• Admin

Omixon Gets CE Mark for SeqOnce Bio Extraction-Free SARS-CoV-2 Detection Kit, Inks Licensing Deal

NEW YORK – Molecular diagnostics company Omixon has obtained CE mark for the AzureSeq-200 RT-PCR kit, an extraction-free viral RNA detection kit to detect SARS-CoV-2. The firm had previously signed an exclusive licensing agreement with SeqOnce Biosciences to obtain CE mark and distribute the kit in Europe, the Middle East, and Africa.

Under the licensing deal, Omixon will now sell Omixon branded CE-marked products licensed from SeqOnce in Europe, Middle East, and Africa, while SeqOnce will sell SeqOnce branded AzureSeq products in the rest of the world. Additional terms of the deal were not disclosed.


Recent Posts

See All

The Next 1000 Forbes List

To shine a light on these entrepreneurial heroes, Forbes has created the Next 1000. This year-round initiative showcases the ambitious sole proprietors, self-funded shops and pre-revenue startups in e

301 North Lake Avenue, Suite 930, Pasadena, CA 91101

© 2021 Wavemaker Three-Sixty Health